Robb Knie's most recent trade in Hoth Therapeutics Inc was a trade of 800,000 Common Stock done . Disclosure was reported to the exchange on Aug. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2025 | 800,000 | 858,131 (8%) | 7% | 0 | Common Stock | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 27 Aug 2025 | 310,744 | 547,387 (5%) | 3% | 1.2 | 376,000 | Common Stock |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2025 | 93,000 | 93,000 | - | - | Options | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2025 | 7,000 | 7,000 | - | - | Options | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 325,000 | 325,000 | - | - | Options | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 16 Aug 2024 | 25,000 | 58,131 (0%) | 0% | 0.7 | 16,750 | Common Stock |
| Hoth Therapeutics Inc | Knie Robb | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 225,000 | 225,000 | - | - | Options | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 40,000 | 40,000 | - | - | Options | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 19 Sep 2022 | 10,000 | 828,259 (8%) | 0% | 0.4 | 3,900 | Common Stock |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 16 Sep 2022 | 10,000 | 818,259 (8%) | 0% | 0.4 | 4,000 | Common Stock |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 500,000 | 500,000 | - | - | Options | |
| Hoth Therapeutics Inc | Robb Knie | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 225,000 | 225,000 | - | - | Options |